UM
Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo
Guo B.1; Xu D.2; Duan H.1; Du J.1; Zhang Z.1; Lee S.M.2; Wang Y.1
2014-02-01
Source PublicationBiological and Pharmaceutical Bulletin
ISSN09186158 13475215
Volume37Issue:2Pages:274-285
AbstractParkinson's disease (PD) is the second most common neurodegenerative disease. Although the etiology of PD is not completely understood, it is well-documented that oxidative stress and Ca-mediated cellular damage play important roles in the progression of PD. 2-[[(1,1-Dimethylethyl) oxidoimino]-methyl]-3,5,6-trimethylpyrazine (TBN), a novel nitrone derivative of tetramethylpyrazine, has shown significant therapeutic effects in stroke models due to its multiple functions, including calcium overload blockade and free radical-scavenging. In this study, we investigated the neuroprotective and neurorescue effects of TBN on various in vitro and in vivo models of PD and explored its possible mechanisms of action. The results show that TBN exerted significant neuroprotection on 1-methyl-4-phenylpyridinium (MPP )-induced damage in SHSY5Y cells and primary dopaminergic neurons, as well as on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neuron loss in zebrafish (TBN and MPTP were added simultaneously into the fish embryo medium and the treatment period was 48 h). In the MPTP-induced mouse and 6-hydroxydopamine (6-OHDA)-induced rat PD models, TBN administrated orally twice daily for 14 d (3 d post-MPTP lesion in mice and 7 d post-6-OHDA lesion in rats) exhibited remarkable neurorescue effects to increase the number of dopaminergic neurons. In addition, TBN improved apomorphine-induced rotational behavior in the 6-OHDA-lesioned PD rats. TBN suppressed the MPP-induced intracellular reactive oxygen species (ROS) in SH-SY5Y cells, increased the superoxide dismutase (SOD) activity and glutathione (GSH) concentration in the substantial nigra of MPTP-treated mice. These data indicate that TBN protects and rescues dopaminergic neurons from MPP and MPTP/6-OHDA-induced damage by reducing ROS and increasing cellular antioxidative defense capability. © 2014 The Pharmaceutical Society of Japan.
Keyword1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 6-hydroxydopamine (6-OHDA) Oxidative stress Parkinson's disease Tetramethylpyrazine nitrone
DOI10.1248/bpb.b13-00743
URLView the original
Language英語
Fulltext Access
Citation statistics
Cited Times [WOS]:26   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionUniversity of Macau
Affiliation1.Jinan University
2.University of Macau
Recommended Citation
GB/T 7714
Guo B.,Xu D.,Duan H.,et al. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo[J]. Biological and Pharmaceutical Bulletin,2014,37(2):274-285.
APA Guo B..,Xu D..,Duan H..,Du J..,Zhang Z..,...&Wang Y..(2014).Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.Biological and Pharmaceutical Bulletin,37(2),274-285.
MLA Guo B.,et al."Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo".Biological and Pharmaceutical Bulletin 37.2(2014):274-285.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Guo B.]'s Articles
[Xu D.]'s Articles
[Duan H.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Guo B.]'s Articles
[Xu D.]'s Articles
[Duan H.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Guo B.]'s Articles
[Xu D.]'s Articles
[Duan H.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.